Vincent Galand is an Affiliate Professor in the Entrepreneurship Department at ESCP Business School, Paris Campus, where he co-created and teaches the School's first deeptech entrepreneurship course. His work sits at the frontier of science-based venture building: he helps scientific founders, healthcare innovators and student teams turn research-stage technologies into investable companies and market strategies. His teaching spans techbio, space technologies, life sciences, quantum, synthetic biology, artificial intelligence, digital health and advanced materials.
He acts as an orchestrator, connecting academia, industry, startups and investors across the European and Asian innovation ecosystems. He founded and co-directs the Digital Health Innovation programme at the Faculty of Medicine and Pharmacy of Université Grenoble Alpes. He contributed to EDITH, the European Commission initiative on Virtual Human Twins in healthcare, where he developed business models and partnerships for the integration of digital twins into health systems.
Vincent advises startups, scale-ups, investment teams and healthcare companies on go-to-market strategy, AI adoption and innovation programmes. A generative AI trainer and executive education speaker for pharmaceutical, biotech, medical device and healthcare organisations, he regularly delivers intensive courses, masterclasses and executive seminars at the intersection of applied AI, regulated healthcare and business transformation.
He serves as a jury member for the CPHI Pharma Awards and Bpifrance's i-PhD national deeptech competition under France 2030, and as a startup evaluator for Bpifrance's Deeptech Seed accelerator. He is an active member of Bpifrance's Deeptech community of Grandes Écoles incubators, and a partner and investor in biotech and deeptech ventures. He speaks and teaches internationally on deeptech entrepreneurship, digital health and generative AI, with engagements across Europe and Asia, including the France-Vietnam Conference on AI for Health.
He holds an MBA from Collège des Ingénieurs, an MSc in Molecular Medicine from Cranfield University and a Master's degree in Biotechnology and Engineering for Health from Université Grenoble Alpes. He completed research training at Massachusetts General Hospital, affiliated with Harvard Medical School and the Harvard Stem Cell Institute, and earlier served as a scientific and academic cooperation attaché at the French Embassy in Poland.
